> Inovio Pharmaceuticals ($INO) has acquired early preclinical therapies aimed at treating Alzheimer's disease and multiple sclerosis from researchers at Fudan University's Shanghai Medical College. Release
> Singapore-based ASLAN Pharmaceuticals will collaborate with CSL Limited ($CSL) to develop the Australian company's anti-IL-13 receptor monoclonal antibody, CSL334, currently in preclinical development for the treatment of asthma. Release
> In a preclinical study, Revive Therapeutics' drug candidate REV-003 had a significant stimulatory effect on respiratory activity in an animal model of human Rett syndrome, a rare disease of the nervous system that can disrupt many body functions, including breathing. Release